GLS — Glenmark Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Glenmark Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	100	1,156	5,122	2,838	3,918
Net Total Accounts Receivable
Net Total Receivables	7,073	7,268	7,152	9,189	7,654
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11,601	13,990	17,646	18,503	19,160
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,498	5,790	6,763	8,242	8,962
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	17,256	19,971	24,710	27,021	28,504
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,075	12,214	3,840	5,044	4,388
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	13,239	12,443	4,167	5,639	5,181
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	4,017	7,527	20,543	21,382	23,323
Total Liabilities & Shareholders' Equity	17,256	19,971	24,710	27,021	28,504
Total Common Shares Outstanding